Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹326 Cr
Jul 2017
- Stocks held
- 27
- Top 10 weight
- 57.7%
- of the portfolio in its ten largest
- Cash & debt
- 7.3%
- cash, money market and debt
- Moves this month
- —
- no earlier month
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In July 2017 it disclosed 27 stocks worth ₹326 Cr. Its largest positions were Sun Pharmaceutical Industries Limited (11.3%), Aurobindo Pharma Limited (9.7%), Strides Pharma Science Limited (6.1%); the ten largest together made up 57.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.6% of its equity. Cash and debt stood at 7.3%.
Against 229 other Sectoral / Thematic funds
Concentration
76%
Top-10 weight is higher than 76% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
85%
Holds more cash than 85% of peers
What these mean: concentration · cash
Holdings in July 2017
Download CSVEvery line the fund disclosed, with the change against the previous month. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
What changed
This is the earliest month on record for the fund.
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
No earlier month with a sector split to compare against.
Allocation in Jul 2017
- Pharmaceuticals & Biotechnology (18)67.6%
- Pharmaceuticals (4)15.5%
- Healthcare Services (4)11.8%
- Finance (1)5.0%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jul 2017
7.3%
- Cash alone
- 7.3%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- —
- lowest to highest · record 7.3% in Jul 2017
Not enough months to draw.
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.